| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.01B | +58.0% |
| R&D Expense | $69.3M | +14.5% |
| SG&A Expense | $81.2M | -25.0% |
| Operating Income | -$411.9M | -14.6% |
| Pre-tax Income | -$426.7M | -10.6% |
| Income Tax | -$1.7M | +37.9% |
| Net Income | -$561.5M | -46.7% |
| EPS (Basic) | -$3.08 | -10.8% |
| EPS (Diluted) | -$3.08 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $337.1M | -9.9% |
| Accounts Receivable | $44.0M | +28.2% |
| Current Assets | $436.9M | +2.0% |
| Total Assets | $1.28B | -6.7% |
| Current Liabilities | $438.8M | +30.1% |
| Total Liabilities | $874.4M | +25.1% |
| Stockholders' Equity | $401.7M | -40.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$316.7M | -64.4% |
| Capital Expenditures | $1.1M | -77.6% |
| Investing Cash Flow | -$12.4M | +83.7% |
| Financing Cash Flow | $296.3M | -42.1% |
| Free Cash Flow | -$317.8M | -60.8% |
| -10.8% |